Sentences with phrase «alnylam pharmaceuticals stock»

Alnylam Pharmaceuticals stock plummeted 45 percent after the therapeutics company announced it was discontinuing its development of revusiran, a therapeutic aimed at treating hereditary ATTR amyloidosis.

Concerns that a Hillary Clinton administration would impose greater price regulation on drug companies had put a damper on pharmaceutical stocks for more than a year.

For Canadians, owning some of these stocks will not only provide income but also diversification, as there are few domestic pharmaceutical stocks to choose from.

While Donald Trump's tweets can shake up pharmaceutical stocks, history suggests that investors have little to fear from the president's drug pricing rhetoric.

In terms of valuation, Valeant Pharmaceuticals stock currently trades at TTM price to sales value of 0.58 x and price to book value of 1.40 x.

And when you're done, be sure to read about which pharmaceutical stocks you should buy now.

Spectrum Pharmaceuticals stock soared 42 % after the company released an update from a promising clinical trial.

As a heads up for this week, pharmaceutical stocks are set to be even more volatile than normal leading up to an...

Here is a chart of Merck, a pharmaceutical stock.

The iShares ETF is the largest covering the sector, tracking a set of biotechnology and pharmaceutical stocks that trade on the Nasdaq stock market.

No. 3: The year of big pharma In the past five years, big cap pharmaceutical stocks have lagged biotech stocks because they've struggled to fill revenue gaps created by the patent cliff.

Any newcomer will have to come to terms not only with the most dismal NCI budget scenario in 3 decades but also with stringent new rules on owning pharmaceutical stock; and because this is a presidential appointment, the director might have less than 2 years to serve.

It could have a dramatic impact on productivity, which in turn could have a major impact on the valuation of pharmaceutical stocks,» he said.

Some examples of defensive sectors include utility, pipeline, pharmaceutical stocks as well as stocks with high dividend payouts.

For example, if a cheap pharmaceutical stock doesn't get FDA approval, your money is gone.

A very common thing I hear from traders is that they «don't trade biotechnology or pharmaceutical stocks.»

Checking pharmaceutical stock to assess inventory level; placing orders; removing outdated drugs.

Maintain pharmacy inventory by checking pharmaceutical stock to determine inventory levels, anticipating needed medications and supplies, placing orders and removing outdated drugs.

Maintain pharmacy inventory by checking pharmaceutical stock to determine inventory level; anticipating needed medications and supplies; placing and expediting orders; verifying receipt; removing outdated drugs.

Ensuring secure and efficient pharmaceutical service to patients, nurses, consultants and other multidisciplinary healthcare unit, the lead pharmacy technician will also be expected to supervise pharmaceutical stock according to established guidelines and will contribute to and oversee all procurement function of the pharmacy department.

Maintains medication inventory by checking pharmaceutical stock on - site to determine inventory level.

Maintains pharmacy inventory by checking pharmaceutical stock to determine inventory level; anticipating needed medications and supplies; placing and expediting orders; verifying receipt; removing outdated drugs.

Maintains pharmacy inventory by checking pharmaceutical stock to determine inventory level, placing expedited orders, verifying receipts and removing outdated drugs

Exciting Pharmacy Technician Position Available Maintain pharmacy inventory by checking pharmaceutical stock to determine inventory levels; anticip...

Maintain pharmacy inventory by checking pharmaceutical stock to determine inventory levels; anticipating and ordering needed medications and supplies

Maintains pharmacy inventory by checking pharmaceutical stock to determine inventory level...

Not exact matches

Allergan: The pharmaceutical company's stock has been a «huge disappointment» the last few quarters, Cramer said.

A sobering example of this is anyone trying to profit from the pharmaceutical innovation with drug stocks.

In 2015, Ackman, the founder of hedge fund Pershing Square, announced his multi-billion dollar bet on Valeant Pharmaceuticals (vrx); he proceeded to lose nearly his entire investment, or $ 7.7 million every day for about two years, as Valeant stock sank 95 %.

Valeant Pharmaceuticals signage is displayed on a monitor on the floor of the New York Stock Exchange before the opening bell on March 21, 2016.

Papa's assurances lost some weight however when reports emerged two days later that the company was still under criminal investigation for potential insurance fraud related to its ties to specialty pharmaceutical Philidor — which erased all of the stock's recent gains.

Shares of beleaguered pharmaceutical Valeant jumped 10 % Wednesday after a team of Morgan Stanley analysts upgraded the stock.

HOUSTON, April 20, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the closing of its previously announced underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares sold pursuant to the underwriters» full exercise of their option to purchase additional shares, at a public offering price of $ 7.50 per share.

After witnessing a 95 % decline in the pharmaceutical company's share price amid a series of scandals, Valeant's board, led by former shareholder and hedge fund manager Bill Ackman, smartly tied Papa's compensation to a recovery in the stock price.

As news emerges of Amazon considering a big push into pharmaceuticals, CNBC's Jim Cramer endorsed one of his favorite drugmakers, Celgene, after its stock fell off a cliff on Thursday.

As pressure mounted over the pharmaceutical giant's rising insulin prices, investors drove its stock down by a third, fearing that policymakers would cap price tags and hurt profits.

On a single - stock basis, Alexion Pharmaceuticals, Wynn Resorts, Lam Research, and Helmerich & Payne were the biggest winners, each adding at least 4.1 %.

BOSTON, April 20 (Reuters)- Alnylam Pharmaceuticals Inc said on Friday that Dicerna Pharmaceuticals Inc will pay it $ 25 million in cash and stock to resolve a lawsuit claiming it stole trade secrets about gene - silencing technology used to develop drug treatments.

Of course, other companies saw their stocks improve with the news, including pharmaceutical firms with Ebola vaccines such as Tekmira Pharmaceuticals (TKMR) and NewLink Genetics (NLNK), whose stocks soared.

HOUSTON, April 17, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a price to the public of $ 7.50 per share.

Left, who has gained notoriety for successful bets against stocks such as Valeant Pharmaceuticals, explained that his rapid change of view on Twitter came as a result of the growing scrutiny surrounding social media and how companies handle users» personal information.

While exorbitant drug price hikes by Martin Shkreli's Turing Pharmaceuticals and Valeant have sparked outrage in Washington and tanked the stock prices of much of the pharmaceutical sector in the last six months, there's growing evidence that the controversy may be more smoke than fire.

HOUSTON, April 16, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock.

Teva Pharmaceuticals has proposed buying rival Mylan for $ 40 billion in cash and stock, as the Israel - based drugmaker looks to gain dominance among generic pharmaceutical companies.

Editor's note: An earlier version of this story said Teva Pharmaceuticals has proposed buying rival Mylan for $ 40 million in cash and stock.

Generic drugmaker Mylan has proposed buying Perrigo for about $ 29 billion in cash and stock in what would be the biggest pharmaceutical deal of the year so far.

Valeant Pharmaceuticals was on an acquisition spree before accounting problems brought down its stock.

Intercept Pharmaceuticals Announces Pricing of Upsized $ 250 Million Public Offering and Concurrent Private Placement of Common Stock

Meanwhile, health care stocks closed higher on Friday recovering from remarks made earlier this week by President - elect Donald Trump that pharmaceuticals were «getting away with murder.»

One of those stocks is Actavis, the large - cap pharmaceutical company that has tripled in returns over the last three years.